Last reviewed: July 7, 2026
Last updated: July 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists like semaglutide have become popular weight loss tools, but questions about pregnancy safety are essential for women of childbearing age. Current evidence suggests these medications should be discontinued before conception, though individual circumstances vary widely. Understanding the timeline, risks, and alternatives helps you make informed decisions about your weight loss journey and future family planning.
What Does Current Research Show About Semaglutide During Pregnancy?
Semaglutide has not been extensively studied in pregnant humans, which is why regulatory guidance errs on the side of caution. Animal studies in rats and mice showed mixed results—some developmental changes appeared at high doses, though effects were not uniformly consistent across all studies. The FDA classifies semaglutide as Category C for pregnancy, meaning risk cannot be ruled out but human data remains limited.
Most medical organizations, including the American College of Obstetricians and Gynecologists, recommend discontinuing GLP-1 medications before attempting conception. This conservative approach reflects the principle that unproven medications should be avoided during pregnancy unless maternal health risks outweigh fetal uncertainties. Your obstetrician and weight loss provider should coordinate timing and alternative strategies if you're planning pregnancy.
Planning Your Weight Loss Timeline Around Pregnancy Goals
If you're considering pregnancy within the next 12–24 months, discussing this timeline with your healthcare provider early helps shape your treatment plan. Some women benefit from intensive weight loss management before conception, which may improve fertility, reduce pregnancy complications, and support postpartum recovery. Others may pause semaglutide therapy and transition to lifestyle-focused approaches as conception attempts begin.
PlexusDx Semaglutide Injection (starting at $149 per month) can be part of a structured pre-conception weight loss phase, allowing you to reach meaningful progress before discontinuing. Your provider can help determine how many months of therapy align with your fertility timeline and health goals. Stopping the medication typically requires a gradual taper rather than abrupt cessation, so planning ahead prevents treatment interruptions.
How Long After Stopping Semaglutide Can You Safely Become Pregnant?
Semaglutide has a half-life of approximately one week, meaning the medication clears your system relatively quickly after the final dose. Most sources recommend waiting at least one to two months after your last injection before actively trying to conceive, though some providers suggest longer intervals for additional safety margins. Since individual metabolism varies, your doctor may recommend blood work or ultrasound confirmation that the medication has fully cleared before attempting pregnancy.
The washout period is also an opportunity to stabilize your weight and develop sustainable eating patterns that will support a healthy pregnancy. Without GLP-1 support, appetite regulation returns gradually, so working with a dietitian during this transition helps prevent rapid weight regain. Many women find that the healthy habits built during semaglutide therapy—portion awareness, consistent physical activity—continue naturally even after medication stops.
Alternative Weight Management Strategies If You're Planning Pregnancy
Lifestyle modifications remain the safest foundation for weight management during the pre-conception period and throughout pregnancy. Moderate-intensity exercise (150 minutes weekly), balanced nutrition emphasizing whole foods, and stress management all support fertility and pregnancy outcomes without medication risks. Working with a registered dietitian who specializes in women's health ensures your nutrition strategy meets both weight loss and conception readiness goals.
If you require ongoing medication support, discuss with your obstetrician whether other FDA-approved options carry lower pregnancy risk for your specific situation. Some women benefit from resuming GLP-1 therapy after delivery, particularly if breastfeeding is not planned, allowing you to regain momentum on your long-term health goals. PlexusDx providers can help coordinate pre-pregnancy, pregnancy, and postpartum treatment planning to align with your complete family-building timeline.
What You Should Discuss With Your Medical Team
Before starting semaglutide or any GLP-1 medication, disclose your pregnancy intentions to both your weight loss provider and primary care doctor. Share your timeline for conception attempts, current fertility status, and any prior pregnancy complications that might influence medication choices. This conversation ensures all providers understand your goals and can coordinate recommendations if circumstances change.
Document the date you discontinue semaglutide and follow your provider's specific guidance about when to attempt conception. Report any unexpected pregnancy symptoms (nausea, missed periods) immediately, and confirm the medication has cleared your system before continuing conception attempts. If you become pregnant while taking semaglutide, contact your healthcare team right away—accidental exposure during early pregnancy requires prompt evaluation but does not necessarily indicate harm.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take semaglutide if I'm trying to get pregnant?
Medical consensus recommends discontinuing semaglutide before attempting conception due to limited human pregnancy data. Work with your provider to establish a timeline for stopping the medication and confirm it has fully cleared your system before conception attempts begin. PlexusDx coordinators can help facilitate this transition with your fertility or obstetric provider.
How does semaglutide affect fertility?
Weight loss from semaglutide may actually improve fertility in women with obesity, as excess weight can disrupt hormone balance and ovulation. However, the medication itself has not been studied for direct effects on reproductive hormones or egg quality. Stopping semaglutide before conception prevents potential risks while preserving the fertility benefits that weight loss provides.
What if I become pregnant while taking semaglutide?
Contact your obstetrician immediately for guidance and evaluation. While animal studies showed some developmental concerns at high doses, accidental exposure during early pregnancy does not automatically predict harm. Your doctor will assess your individual risk factors and monitor your pregnancy with appropriate testing to ensure fetal wellbeing.
How much does semaglutide therapy cost with PlexusDx?
PlexusDx Semaglutide Injection starts at $149 per month from licensed 503A compounding pharmacies, with no insurance required and HSA/FSA eligibility available. Your dose may increase over time for optimal results, but your monthly price remains flat—you never pay more as your dose climbs. This allows you to pursue intensive pre-conception weight loss without escalating medication costs.
Can genetic testing help me prepare for pregnancy while on weight loss therapy?
PlexusDx Precision Peptide Genetic Test ($99 add-on after first treatment month) analyzes 14 metabolic pathways and 49 peptides to identify how your genetics influence weight regulation, appetite hormones, and insulin sensitivity. Understanding your peptide-pathway genetics helps optimize your pre-conception weight loss strategy and informs sustainable habits you'll carry into pregnancy and beyond.
Should I stop semaglutide gradually or suddenly when planning pregnancy?
Your healthcare provider should guide a taper schedule rather than abrupt cessation, as gradual reduction may minimize appetite rebound and weight gain. Discuss your specific taper plan at least one to two months before your target conception date to allow adequate washout time. PlexusDx providers work with your obstetrician to coordinate the discontinuation timeline with your overall fertility plan.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Should You Eat on Wegovy for Sustainable Weight Loss Results?
Optimizing Your Eating Schedule: How Often to Eat on Ozempic